FSD Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc., a biopharmaceutical company, has successfully secured over $3 million CAD in arbitration awards against its former CEO, Dr. Raza Bokhari, with the U.S. District Court for the Eastern District of Pennsylvania confirming the awards. The legal victory comes after Bokhari challenged his termination from the company, leading to years of litigation and arbitration. FSD Pharma now seeks final judgment on the financial awards, which include interest accruing since 2022.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
